Genentech—Independent Medical Education

Grants for IME for the following disease states: Disease States: Acute Myeloid Leukemia, Age-related Macular Degeneration, ALK-Positive Non-small cell lung cancer, basal cell carcinoma, bladder cancer, Chronic Lymphocytic Leukemia, Diabetic Macular Edema, Diabetic Retinopathy, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Gastrointestinal Cancer, Genitourinary Cancer, Giant Cell Arteritis, Hematologic Malignancy, Hemophilia, Hepatocellular Carcinoma, HER2 Positive Breast Cancer, Hormone Receptor Positive Breast Cancer, Idiopathic Pulmonary Fibrosis, Influenza, Lung Cancer, NTRK Fusion Cancers, Ovarian Cancer, Pan-Tumor, Pemphigus Vulgaris, Renal Cell Carcinoma, ROS1 Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Stroke, Systemic Scleroderma, Triple Negative Breast Cancer, Vasculitis. Occasionally the company releases RFPs for specific disease states, which have specific deadlines. 

Dollar Amount: Varies 

Deadline: Rolling 

Eligibility: Requests for funding an ACCME accredited program must be submitted by the organization accrediting the activity (the accredited provider) regardless of the dollar amount requested. Requests for funding other accredited programs (i.e., pharmacy, nursing, AAFP) must be submitted by the organization that is responsible for development of the program's content. 

Full RFP: https://www.gene.com/good/giving/corporate-giving/imed 

Contact Us

Questions?  We're here to help. Contact us for assistance seeking or stewarding private funding.

Contact Us